INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Public company

VTYXVentyx Biosciences, Inc.

CIK 0001851194

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score9
Connections2with evidence

VTYX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
5,313 sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Gonzales RoySenior VP, Finance · Mar 4, 2026
9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D
—
109.2K sh
Mar 4, 2026
Mar 4, 2026
traded Mar 4, 2026
+0d
SEC FORM 4

Evidence

9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
17.5K sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
12.5K sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
35.0K sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
37.5K sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

9
GR
Gonzales RoySenior VP, Finance
VTYXVentyx Biosciences, Inc.
Disposition to issuer
D—
70.0K sh
Mar 4, 2026Mar 4, 2026
traded Mar 4, 2026
+0dSEC FORM 4

Evidence

Source error

Price history for VTYX is unavailable.

An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.